GAINERS:
- Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 240.88% at $28.77
- SOL Glb Inv (OTC:SOLCF) shares closed up 31.58% at $0.08
- C21 Investments (OTC:CXXIF) shares closed up 19.59% at $0.41
- Rocky Mountain High (OTC:RMHB) shares closed up 16.67% at $0.00
- Khiron Life Sciences (OTC:KHRNF) shares closed up 15.00% at $0.01
- Affinor Growers (OTC:RSSFF) shares closed up 14.19% at $0.12
- Trees (OTC:CANN) shares closed up 7.45% at $0.09
- Body and Mind (OTC:BMMJ) shares closed up 7.23% at $0.09
- OrganiGram Holdings (NASDAQ:OGI) shares closed up 4.75% at $1.70
- 22nd Century Group (NASDAQ:XXII) shares closed up 4.71% at $0.18
- Eastside Distilling (NASDAQ:EAST) shares closed up 3.67% at $1.13
- Pharmadrug (OTC:LMLLF) shares closed up 3.50% at $0.03
- Psychemedics (NASDAQ:PMD) shares closed up 3.17% at $3.25
- Curaleaf Holdings (OTC:CURLF) shares closed up 3.02% at $5.11
LOSERS:
- Blueberries Medical (OTC:BBRRF) shares closed down 27.49% at $0.02
- 1933 Industries (OTC:TGIFF) shares closed down 22.73% at $0.01
- Target Group (OTC:CBDY) shares closed down 20.00% at $0.00
- Item 9 Labs (OTC:INLB) shares closed down 16.67% at $0.00
- MJ Holdings (OTC:MJNE) shares closed down 10.94% at $0.02
- CNBX Pharmaceuticals (OTC:CNBX) shares closed down 9.15% at $0.01
- iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 8.59% at $0.03
- RIV Capital (OTC:CNPOF) shares closed down 6.68% at $0.09
- 4Front Ventures (OTC:FFNTF) shares closed down 5.98% at $0.11
- Genetic Technologies (NASDAQ:GENE) shares closed down 5.42% at $1.92
- Emeren Group (NYSE:SOL) shares closed down 4.88% at $1.95
- Cresco Labs (OTC:CRLBF) shares closed down 4.37% at $1.97
- cbdMD (AMEX:YCBD) shares closed down 4.32% at $0.77
- Indiva (OTC:NDVAF) shares closed down 3.98% at $0.07
- Cronos Group (NASDAQ:CRON) shares closed down 3.94% at $1.95
- Cannabix Technologies (OTC:BLOZF) shares closed down 3.57% at $0.15
- Tilray Brands (NASDAQ:TLRY) shares closed down 3.52% at $1.92
- Auxly Cannabis Group (OTC:CBWTF) shares closed down 3.11% at $0.01
This article was generated by Benzinga's automated content engine and reviewed by an editor.